Author: Isley William L
Publisher: Informa Healthcare
ISSN: 1474-0338
Source: Expert Opinion on Drug Safety, Vol.2, Iss.6, 2003-11, pp. : 581-586
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Hepatotoxicity with Thiazolidinediones: Is it a Class Effect?
By Scheen A.J.
Drug Safety, Vol. 24, Iss. 12, 2001-01 ,pp. :
Reduced potential for hepatotoxicity with newer thiazolidinediones?
Inpharma, Vol. 1, Iss. 1379, 2003-01 ,pp. :
The safety of thiazolidinediones
Expert Opinion on Drug Safety, Vol. 10, Iss. 3, 2011-05 ,pp. :
Pharmacokinetic Interactions with Thiazolidinediones
Clinical Pharmacokinetics, Vol. 46, Iss. 1, 2007-01 ,pp. :
Influence of thiazolidinediones on insulin action
Inpharma, Vol. 1, Iss. 1383-1384, 2003-01 ,pp. :